Fluorescence Imaging of IBD and RA Using Adalimumab-800CW

NCT03938701 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

IBD
Rheumatoid Arthritis

Interventions

DRUG: Adalimumab-800CW
DEVICE: Fluorescence Imaging

Sponsor

University Medical Center Groningen

Collaborators

[object Object]